Swing Therapeutics was founded in 2019 with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics’ near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.
Location: United States, California, San Francisco
Member count: 11-50
Total raised: $19.3M
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Kicker Ven... | kickervent... |
| - | JAZZ Ventu... | jazzvp.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 17.06.2022 | Series A | $10.3M | - | vator.tv/n... |
| 11.08.2021 | Seed | $9M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 17.06.2022 | Swing Ther... | Swing Therapeutics, a San Fran... | USA | - | finsmes.co... |
| 17.06.2022 | Swing Ther... | Its first products are treatme... | - | Steven Loe... | vator.tv/n... |
| 11.08.2021 | Swing Ther... | Swing Therapeutics, a San Fran... | USA | - | finsmes.co... |